India's Tobacco Control Efforts Hindered by Online Cigarette Sales
According to a report from The Times of India on November 5th, India is facing a significant challenge with the rise of online cigarette sales, which is greatly impeding the country's efforts in tobacco control. Additionally, there has been a rapid increase in the number of head and neck cancer cases in India.
Dr. Pankaj Chaturvedi, Deputy Director of the Tata Memorial Centre in India and a renowned anti-tobacco advocate, has expressed concern over India's high burden of oral cancer, which accounts for nearly one-third of global cases. According to Dr. Chaturvedi, tobacco products are the main culprit behind this issue. He further pointed out that online sales and the unrestricted availability of loose cigarettes are not subject to any regulatory oversight in India.
Another report has indicated that the use of smokeless tobacco is quite prevalent, particularly among tribal communities in India. In 2020, the cost of treating oral cancer in India amounted to 2.386 billion rupees, which was covered by insurance plans, government and private sector expenditures, out-of-pocket expenses, and charitable donations. Over the next decade, this is projected to result in an economic burden of 23.724 billion rupees.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
